News | June 23, 2025
BASF opens new GMP Solution Center in US
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of migraine in adult patients with a history of four or more migraine days per month
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
The company received seven observations in the Form-483
The inspection concluded successfully, with the facility found to be in compliance with the required regulations
The company received one observation in the Form-483
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
Now approved for both acute and chronic HCV in adults and children aged 3 and above
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
The company received 1 (One) observation in the Form-483
Subscribe To Our Newsletter & Stay Updated
